FONES

From Covid to Hormuz: Switzerland's Drug Supply Chain Remains at Risk

The conflict disrupting the Strait of Hormuz has renewed concerns over Switzerland's fragile pharmaceutical supply chains, a vulnerability exposed during the Covid-19 pandemic. The Federal Office for National Economic Supply confirms that essential medicines remain the primary category at risk of shortages.